Emergent Biosolutions
EBS
EBS
191 hedge funds and large institutions have $465M invested in Emergent Biosolutions in 2023 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 54 increasing their positions, 72 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
12% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 34
25% less repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 72
Holders
191
Holding in Top 10
–
Calls
$1.86M
Puts
$1.27M
Top Buyers
| 1 | +$5.62M | |
| 2 | +$5.28M | |
| 3 | +$4.21M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$3.16M |
| 5 |
BlackRock
New York
|
+$3.14M |
Top Sellers
| 1 | -$13.1M | |
| 2 | -$10.4M | |
| 3 | -$4.27M | |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$3.68M |
| 5 |
Renaissance Technologies
New York
|
-$3.59M |